GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verrica Pharmaceuticals Inc (STU:1NE) » Definitions » Forward Dividend Yield %

Verrica Pharmaceuticals (STU:1NE) Forward Dividend Yield % : 0.00% (As of Sep. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Verrica Pharmaceuticals Forward Dividend Yield %?

As of today (2024-09-21), the Forward Annual Dividend Yield of Verrica Pharmaceuticals is 0.00%.

As of today (2024-09-21), the Trailing Annual Dividend Yield of Verrica Pharmaceuticals is 0.00%.

STU:1NE's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59
* Ranked among companies with meaningful Forward Dividend Yield % only.

Verrica Pharmaceuticals's Dividends per Share for the three months ended in Jun. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Verrica Pharmaceuticals's Forward Dividend Yield %

For the Biotechnology subindustry, Verrica Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verrica Pharmaceuticals's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verrica Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Verrica Pharmaceuticals's Forward Dividend Yield % falls into.



Verrica Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Verrica Pharmaceuticals  (STU:1NE) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Verrica Pharmaceuticals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Verrica Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Verrica Pharmaceuticals Business Description

Traded in Other Exchanges
Address
44 West Gay Street, Suite 400, West Chester, PA, USA, 19380
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals Headlines

No Headlines